An immunochemical study of the lymphocyte A, Atri system

Area of Science:

• Immunology and Serology
• Biochemistry of Carbohydrates

Background:

• Lymphocytotoxic antibodies are crucial in transfusion medicine and transplantation.
• The Atri blood group substance is a rare antigen identified in a small percentage of the population.
• Understanding the immunochemical properties of rare blood group antigens is vital for clinical practice.

Purpose of the Study:

• To characterize the immunochemical specificity of anti-Atri antibodies.
• To identify the specific carbohydrate structures that inhibit anti-Atri antibody reactions.
• To determine the immunodominant epitope of the Atri blood group substance.

Main Methods:

• An inhibition assay was employed using anti-Atri lymphocytotoxic antibodies.
• Nineteen different oligosaccharidic structures containing A, B, H, or Lewis blood group determinants were used as inhibitors.
• The reactivity of antibodies was tested against target cells in the presence of inhibitor structures.

Main Results:

• Observed inhibitions demonstrated a clear dissociation between A, H blood group substances and the Atri substance.
• The results indicate that fucosyl residues play a significant role in the reactivity of the Atri substance.
• Specifically, fucosyl alpha (1 to 3) appears to be a critical component for antibody binding.

Conclusions:

• The Atri blood group substance is immunochemically distinct from A and H blood group antigens.
• Fucosyl residues, particularly fucosyl alpha (1 to 3), are likely the immunodominant determinants of the Atri substance.
• This finding contributes to the understanding of rare blood group antigen structures and antibody specificities.